Skip to results
1-12 of 12
Authors: Samuel H. Cheshier
Sort by
Journal Article
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma Free
Calixto-Hope G Lucas and others
Journal of Neuropathology & Experimental Neurology, Volume 81, Issue 8, August 2022, Pages 650–657, https://doi.org/10.1093/jnen/nlac044
Published: 15 June 2022
Journal Article
Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles Free
Michael Zhang and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 986–994, https://doi.org/10.1093/neuonc/noab272
Published: 25 November 2021
Journal Article
MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study Open Access
Lydia T Tam and others
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab042, https://doi.org/10.1093/noajnl/vdab042
Published: 05 March 2021
Journal Article
ATRT-25. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON ATYPICAL RHABDOID TERATOID TUMOR (ATRT) AND IS A PROMISING CANDIDATE FOR CAR T CELL THERAPY Free
Johanna Theruvath and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i33, https://doi.org/10.1093/neuonc/noy059.023
Published: 22 June 2018
Journal Article
IMMU-45. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON MEDULLOBLASTOMA AND PROVES TO BE A PROMISING CANDIDATE FOR CAR T CELL IMMUNOTHERAPY Free
Johanna Theruvath and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi122, https://doi.org/10.1093/neuonc/nox168.503
Published: 06 November 2017
Journal Article
IMMU-49. TARGETING CCR2 SIGNALING IN PEDIATRIC MEDULLOBLASTOMA Free
Amy-Lee Bredlau and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi123, https://doi.org/10.1093/neuonc/nox168.507
Published: 06 November 2017
Journal Article
TMIC-04. A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA Free
Gregor Hutter and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi243–vi244, https://doi.org/10.1093/neuonc/nox168.994
Published: 06 November 2017
Journal Article
IMMU-07. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON MEDULLOBLASTOMA AND PROVES TO BE A PROMISING CANDIDATE FOR CAR T CELL IMMUNOTHERAPY Free
Johanna Theruvath and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Pages iv28–iv29, https://doi.org/10.1093/neuonc/nox083.117
Published: 31 May 2017
Journal Article
Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma
Get access
Robert C. Rennert and others
in
Stem Cells
Stem Cells, Volume 34, Issue 6, June 2016, Pages 1702–1707, https://doi.org/10.1002/stem.2359
Published: 28 March 2016
Journal Article
PM-08A HUMANIZED CO-TRANSPLANT XENOGRAFT MOUSE MODEL, TO STUDY TOXICITY OF DRUGS TARGETED AGAINST PEDIATRIC BRAIN TUMORS
Get access
Sharareh Gholamin and others
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii32, https://doi.org/10.1093/neuonc/nov061.130
Published: 21 April 2015
Journal Article
EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT
Get access
Yoon-Jae Cho and others
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii25, https://doi.org/10.1093/neuonc/nou208.9
Published: 01 July 2014
Advertisement
Advertisement